DEVELOPMENT OF VACCINE AGAINST CORONAVIRUS DISEASE 2019 (COVID-19) IN INDIA
RAYEES A. RATHER
Department of Botany, University of Kashmir, Srinagar-190006, Jammu and Kashmir, India.
TAJAMUL ISLAM
*
Department of Botany, University of Kashmir, Srinagar-190006, Jammu and Kashmir, India.
ISHFAQ UL REHMAN
Department of Botany, University of Kashmir, Srinagar-190006, Jammu and Kashmir, India.
DIGVIJAY PANDEY
Department of Technical Education, IET, Lucknow, India.
*Author to whom correspondence should be addressed.
Abstract
The pandemic declaration of Covid-19 infection by World Health Organization (WHO) and ensuing boundless morbidities and mortalities in practically all nations of the world prompted the innovative work to discover an immunization against SARS-CoV2 infection. Typically any new vaccine takes 10–15 y time. In pandemic circumstance, the whole cycle of vaccine development including clinical preliminaries gets shortened and optimized to 10–14 month time. i.e. the quest for vaccine against Covid-19 is going on at a high speed coming with the good news of two vaccines Covishield and Covaxin. This review aims at highlighting the present stages of development of vaccinesin Indian scenario.
Keywords: Coronavirus, covaxin, covishield, clinical, vaccines.